首页> 外国专利> HUMAN SEBOCYTE PRECURSOR CELLS, HUMAN SEBOCYTES AND IN VITRO METHODS FOR OBTAINING THE SAME FROM HUMAN INDUCED PLURIPOTENT STEM CELLS (HIPSC)

HUMAN SEBOCYTE PRECURSOR CELLS, HUMAN SEBOCYTES AND IN VITRO METHODS FOR OBTAINING THE SAME FROM HUMAN INDUCED PLURIPOTENT STEM CELLS (HIPSC)

机译：从人诱导的多能干细胞（HIPSC）中获得相同抗体的人类核细胞前体细胞，人类核细胞和体外方法

页面导航

摘要
著录项
相似文献

摘要

One aspect of the invention relates to an in vitro method for obtaining hiPSC-derived sebocyte precursor cells comprising the steps of:a) culturing, under feeder layer-free conditions, human induced pluripotent stem cells (hiPSC) in a sebocyte basal medium complemented with a combination of (i) retinoic acid (RA), (ii) bone morphogenetic protein 4 (BMP4) and (iii) epidermal growth factor (EGF), during a period of time ranging from about 5 days to about 15 days, so as to generate multipotent skin precursor cells,b) culturing, under feeder layer-free conditions, the multipotent skin precursor cells obtained at step a) in a sebocyte differentiation basal medium, during a period of time ranging from about 5 days to about 15 days, so as to generate hiPSC-derived sebocyte precursor cells, andc) collecting the hiPSC-derived sebocyte precursor cells obtained at step b).

机译：本发明的一个方面涉及一种用于获得hiPSC衍生的皮脂细胞前体细胞的体外方法，该方法包括以下步骤：a）在无饲养层的条件下，在皮脂细胞基础培养基中培养人诱导的多能干细胞（hiPSC），辅以（i）视黄酸（RA），（ii）骨形态发生蛋白4（BMP4）和（ iii）表皮生长因子（EGF），在大约5天到大约15天的时间范围内，以产生多能的皮肤前体细胞，b）在无饲养层的条件下，在皮脂细胞分化基础培养基中，在约5天至约15天的时间段内，培养步骤a）中获得的多能皮肤前体细胞，以产生源自hiPSC的细胞皮脂细胞前体细胞，以及c）收集在步骤b）获得的源自hiPSC的皮脂细胞前体细胞。 展开▼

著录项

公开/公告号EP3284817A1

专利类型

公开/公告日2018-02-21

原文格式PDF

申请/专利权人 PHENOCELL;
展开▼

申请/专利号EP20160306065

发明设计人 ONTENIENTE BRIGITTE;MARUOTTI JULIEN;
展开▼

申请日2016-08-18

分类号C12N5/071;G01N33/50;

国家 EP

入库时间 2022-08-21 13:15:32

相似文献

专利

外文文献

中文文献

1. 通过移除组蛋白H3-赖氨酸三甲基化增加人类体细胞核转移(SCNT)效率，以及增加人类NT-ESC衍生物的方法和组合物 [P] . 中国专利： CN109641015A . 2019-04-16

2. 一种分离来源于人类诱导多能干细胞的成纤维细胞的方法及其应用 [P] . 中国专利： CN113462639A . 2021-10-01

3. HUMAN SEBOCYTE PRECURSOR CELLS, HUMAN SEBOCYTES AND IN VITRO METHODS FOR OBTAINING THE SAME FROM HUMAN INDUCED PLURIPOTENT STEM CELLS (hiPSC). [P] . 世界知识产权组织专利： WO2018033622A1 . 2018-02-22

机译：从人诱导的多能干细胞（hiPSC）中获取人核糖核酸前体细胞，人核糖体和体外方法。

4. Method for in vitro detection of the proarrhythmogenic risk of a drug candidate on human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) [P] . 美国专利： US2020132665A1 . 2020-04-30

机译：体外检测人源多能干细胞源性心肌细胞（hiPSC-CM）候选药物促心律失常风险的方法

5. METHOD FOR IN VITRO DETECTION OF THE PROARRHYTHMOGENIC RISK OF A DRUG CANDIDATE ON HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES (HIPSC-CM) [P] . 欧洲知识产权局专利： EP3546935A1 . 2019-10-02

机译：体外检测人源性多潜能干细胞衍生的心肌细胞（HIPSC-CM）药物候选毒品候选药物的原发性遗传风险

1. Generation of induced pluripotent stem cells from human β-thalassemia fibroblast cells [J] . Yixuan Wang, Yonghua Jiang, Sheng Liu, 细胞研究（英文版） . 2009,第009期

2. Comparative analysis of targeted differentiation of human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells reveals variability associated with incomplete transgene silencing in retrovirally derived hiPSCs lines [J] . ToivonenS., OjalaM., HyysaloA., Stem cells translational medicine. . 2013,第2期

3. Comparative Analysis of Targeted Differentiation of Human Induced Pluripotent Stem Cells (hiPSCs) and Human Embryonic Stem Cells Reveals Variability Associated With Incomplete Transgene Silencing in Retrovirally Derived hiPSC Lines [J] . Sanna Toivonen, Marisa Ojala, Anu Hyysalo, Stem cells translational medicine. . 2013,第2期

4. Systematic evaluation of markers used for the identification of human induced pluripotent stem cells Systematic evaluation of markers used for the identification of human induced pluripotent stem cells Systematic evaluation of markers used for the identification of human induced pluripotent stem cells [J] . Alok Srivastava, Shaji Ramachandran Velayudhan, Kannan Vrindavan Manian, Biology Open . 2017,第1期

5. Proteomics Profiling of Cellular Reprogramming: Are Human Induced Pluripotent Stem Cells (hiPSCs) Indistin guishable from Human Embryonic Stem Cells (hESCs)? [C] . Javler Monoz, Teck Yew Low, Yee Jun Kok, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2010

6. Engineering Human Induced Pluripotent Stem Cells (hiPSCs) to Investigate the Contribution of the APOE Risk Allele to the Onset and Progression of Alzheimer’s Disease [D] . Brookhouser, Nick. 2020

7. Comparative Analysis of Targeted Differentiation of Human Induced Pluripotent Stem Cells (hiPSCs) and Human Embryonic Stem Cells Reveals Variability Associated With Incomplete Transgene Silencing in Retrovirally Derived hiPSC Lines [O] . Sanna Toivonen, Marisa Ojala, Anu Hyysalo, 2013

8. Poster session 2Morphogenetic mechanisms290MiR-133 regulates retinoic acid pathway during early cardiac chamber specification291Bmp2 regulates atrial differentiation through miR-130 during early heart looping formationDevelopmental genetics294Association of deletion allele of insertion/deletion polymorphism in alpha 2B adrenoceptor gene and hypertension with or without type 2 diabetes mellitus295Association of G1359A polymorphism of the endocannabinoid type 1 receptor (CNR1) with coronary artery disease (CAD) with type 2 diabetes mellitusCell growth, differentiation and stem cells - Vascular298Gamma-secretase inhibitor prevents proliferation and migration of ductus arteriosus smooth muscle cells: a role of Notch signaling in postnatal closure of ductus arteriosus299Mesenchymal stromal-like cells (MLCs) derived from induced pluripotent stem (iPS) cells: a promising therapeutic option to promote neovascularization300Sonic Hedgehog promotes mesenchymal stem cell differentiation to vascular smooth muscle cells in cardiovacsular disease301Proinflammatory cytokine secretion and epigenetic modification in endothelial cells treated LPS-GinfivalisCell death and apoptosis - Vascular304Mitophagy acts as a safeguard mechanism against human vascular smooth muscle cell apoptosis induced by atherogenic lipidsTranscriptional control and RNA species - Vascular307MicroRNA-34a role in vascular calcification308Local delivery of a miR-146a inhibitor utilizing a clinically applicable approach attenuates neointima formation after vascular injury309Long noncoding RNA landscape of hypoxic endothelial cells310Specific circulating microRNAs levels associate with hypertension, hyperglycemia and dysfunctional HDL in acute coronary syndrome patientsCytokines and cellular inflammation - Vascular313Phosphodiesterase5A up-regulation in vascular endothelium under pro-inflammatory conditions: a newly disclosed anti-inflammatory activity for the omega-3polyunsaturated aatty acid docosahexaenoic acid314Cardiovascular risk modifying with extra-low dose anticytokine drugs in rhematoid arthritis315Conversion of human M-CSF macrophages into foam cells reduces their proinflammatory responses to classical M1-polarizing activation316Lymphocytic myocarditis coincides with increased plaque inflammation and plaque hemorrhage in coronary arteries, facilitating myocardial infarction317Serum osteoprotegerin level predictsdeclined numerous of circulating endothelial- derived and mononuclear-derived progenitor cells in patients with metabolic syndromeGrowth factors and neurohormones - Vascular320Effect of gastrin-releasing peptide (GRP) on vascular inflammationSignal transduction - Heart323A new synthetic peptide regulates hypertrophy in vitro through means of the inhibition of nfkb324Inducible fibroblast-specific knockout of p38 alpha map kinase is cardioprotective in a mouse model of isoproterenol-induced cardiac hypertrophy325Regulation of beta-adrenoceptor-evoked inotropic responses by inhibitory G protein, adenylyl cyclase isoforms 5 and 6 and phosphodiesterases326Binding to RGS3 and stimulation of M2 muscarinic acetylcholine receptors modulates the substrate specificity of p190RhoGAP in cardiac myocytes327Cardiac regulation of post-translational modifications, parylation and deacetylation in LMNA dilated cardiomyopathy mouse model328Beta-adrenergic regulation of the b56delta/pp2a holoenzyme in cardiac myocytes through b56delta phosphorylation at serine 573Nitric oxide and reactive oxygen species - Vascular331Oxidative stress-induced miR-200c disrupts the regulatory loop among SIRT1, FOXO1 and eNOS332Antioxidant therapy prevents oxidative stress-induced endothelial dysfunction and Enhances Wound Healing333Morphological and biochemical characterization of red blood cell in coronary artery diseaseCytoskeleton and mechanotransduction - Heart336Novel myosin activator, JSH compounds, increased myocardial contractility without chronotropic effect in ratsExtracellular matrix and fibrosis - Vascular339Ablation of Toll-like receptor 9 causes cardiac rupture after myocardial infarction by attenuating proliferation and differentiation of cardiac fibroblasts340Altered vascular remodeling in the mouse hind limb ischemia model in Factor VII activating protease (FSAP) deficiencyVasculogenesis, angiogenesis and arteriogenesis343Pro-angiogenic effects of proly-hydroxylase inhibitors and their potential for use in a novel strategy of therapeutic angiogenesis for coronary total occlusion344Nrf2 drives angiogenesis in transcription-independent manner: new function of the master regulator of oxidative stress response345Angiogenic gene therapy, despite efficient vascular growth, is not able to improve muscle function in normoxic or chronically ischemic rabbit hindlimbs -role of capillary arterialization and shunting346Effect of PAR-1 inhibition on collateral vessel growth in the murine hind limb model347Quaking is a key regulator of endothelial cell differentiation, neovascularization and angiogenesis348"Emerging angiogenesis" in the chick chorioallantoic membrane (CAM). An in vivo study349Exosomes from cardiomyocyte progenitor cells and mesenchymal stem cells stimulate angiogenesis in vitro and in vivo via EMMPRINEndothelium352Reciprocal regulation of GRK2 and bradykinin receptor stimulation modulate Ca2+ intracellular level in endothelial cells353The roles of bone morphogenetic proteins 9 and 10 in endothelial inflammation and atherosclerosis354The contribution of GPR55 to the L-alpha-lysophosphatidylinositol-induced vasorelaxation in isolated human pulmonary arteries355The endothelial protective ACE inhibitor Zofenoprilat exerts anti-inflammatory activities through H2S production356A new class of glycomimetic drugs to prevent free fatty acid-induced endothelial dysfunction357Endothelial progenitor cells to apoptotic endothelial cell-derived microparticles ration differentiatesas preserved from reduced ejection fractionheart failure358Proosteogenic genes are activated in endothelial cells of patients with thoracic aortic aneurysm359Endothelin ETB receptors mediate relaxing responses to insulin in pericardial resistance arteries from patients with cardiovascular disease (CVD)Smooth muscle and pericytes362CX3CR1 positive myeloid cells regulate vascular smooth muscle tone by inducing calcium oscillations via activation of IP3 receptors363A novel function of PI3Kg on cAMP regulation, role in arterial wall hyperplasia through modulation of smooth muscle cells proliferation364NRP1 and NRP2 play important roles in the development of neointimal hyperplasia in vivo365Azithromycin induces autophagy in aortic smooth muscle cellsCoagulation, thrombosis and platelets368The real time in vivo evaluation of platelet-dependent aldosterone prothrombotic action in mice369Development of a method for in vivo detection of active thrombi in mice370The antiplatelet effects of structural analogs of the taurine chloramine371The influence of heparin anticoagulant drugs on functional state of human platelets372Regulation of platelet aggregation and adenosine diphosphate release by d dimer in acute coronary syndrome (in vitro study)Oxygen sensing, ischaemia and reperfusion375Sirtuin 5 mediates brain injury in a mouse model of cerebral ischemia-reperfusion376Abscisic acid: a new player in cardiomyocyte protection from ischaemia?377Protective effects of ultramicronized palmitoylethanolamide (PEA-um) in myocardial ischaemia and reperfusion injury in vivo378Identification of stem cell-derived cardiomyocytes using cardiac specific markers and additional testing of these cells in simulated ischemia/reperfusion system379Single-dose intravenous metformin treatment could afford significant protection of the injured rat kidney in an experimental model of ischemia-reperfusion380Cardiotoxicity of long acting muscarinic receptor antagonists used for chronic obstructive pulmonary disease381Dependence antioxidant potential on the concentration of amino acids382The impact of ischemia-reperfusion on physiological parameters,apoptosis and ultrastructure of rabbit myocardium with experimental aterosclerosisMitochondria and energetics385MicroRNA-1 dependent regulation of mitochondrial calcium uniporter (MCU) in normal and hypertrophied hearts386Mitochondrial homeostasis and cardioprotection: common targets for desmin and aB-crystallin387Overexpression of mitofusin-2 (Mfn2) and associated mitochondrial dysfunction in the diabetic heart388NO-dependent prevention of permeability transition pore (MPTP) opening by H2S and its regulation of Ca2+ accumulation in rat heart mitochondria389G protein coupled receptor kinase 2 (GRK2) is fundamental in recovering mitochondrial morphology and function after exposure to ionizing radiation (IR)Gender issues392Sex differences in pulmonary vascular control; focus on the nitric oxide pathwayAging395Heart failure with preserved ejection fraction develops when feeding western diet to senescence-accelerated mice396Cardiovascular markers as predictors of cognitive decline in elderly hypertensive patients397Changes in connexin43 in old rats with volume overload chronic heart failureGenetics and epigenetics400Calcium content in the aortic valve is associated with 1G>2G matrix metalloproteinase 1 polymorphism401Neuropeptide receptor gene s (NPSR1) polymorphism and sleep disturbances402Endothelin-1 gene Lys198Asn polymorphism in men with essential hypertension complicated and uncomplicated with chronic heart failure403Association of common polymorphisms of the lipoprotein lipase and pon1 genes with the metabolic syndrome in a sample of community participantsGenomics, proteomics, metabolomics, lipidomics and glycomics405Gene expression quantification using multiplexed color-coded probe pairs to determine RNA content in sporadic cardiac myxoma406Large-scale phosphorylation study of the type 2 diabetic heart subjected to ischemia / reperfusion injury407Transcriptome-based identification of new anti-inflammatory properties of the olive oil hydroxytyrosol in vascular endothelial cell under basal and proinflammatory conditions408Gene polymorphisms combinations and risk of myocardial infarctionComputer modelling, bioinformatics and big data411Comparison of the repolarization reserve in three state-of-the-art models of the human ventricular action potentialMetabolism, diabetes mellitus and obesity414Endothelial monocyte-activating polypeptide-II improves heart function in type -I Diabetes mellitus415Admission glucose level is independent predictor of impaired left ventricular function in patients with acute myocardial infarction: a two dimensional speckle-tracking echocardiography study416Association between biochemical markers of lipid profile and inflammatory reaction and stiffness of the vascular wall in hypertensive patients with abdominal obesity417Multiple common co-morbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress and myocardial stiffening418Investigating the cardiovascular effects of antiretroviral drugs in a lean and high fat/sucrose diet rat model of obesity419Statins in the treatment of non-alcoholic steatohepatitis (NASH). Our experience from a 2-year prospective study in Constanta County, Romania420Epicardial adipose tissue as a predictor of cardiovascular outcome in patients with ACS undergoing PCI?Arterial and pulmonary hypertension423Dependence between heart rhythm disorers and ID polymorphism of ACE gene in hypertensive patients424Molecular mechanisms underlying the beneficial effects of Urocortin 2 in pulmonary arterial hypertension425Inhibition of TGf-b axis and action of renin-angiotensin system in human ascending aorta aneurysms426Early signs of microcirculation and macrocirculation abnormalities in prehypertension427Vascular smooth muscle cell-expressed Tie-2 controls vascular tone428Cardiac and vascular remodelling in the development of chronic thrombo-embolic pulmonary hypertension in a novel swine modelBiomarkers431Arrhythmogenic cardiomyopathy: a new, non invasive biomarker432Can circulating microRNAs distinguish type 1 and type 2 myocardial infarction?433Design of a high-throughput multiplex proteomics assay to identify left ventricular diastolic dysfunction in diabetes434Monocyte-derived and P-selectin-carrying microparticles are differently modified by a low fat diet in patients with cardiovascular risk factors who will and who will not develop a cardiovascular event435Red blood cell distribution width assessment by polychromatic interference microscopy of thin films in chronic heart failure436Invasive and noninvasive evaluation of quality of radiofrequency-induced cardiac denervation in patients with atrial fibrillation437The effect of therapeutic hypothermia on the level of brain derived neurotrophic factor (BDNF) in sera following cardiopulmonary resustitation438Novel biomarkers to predict outcome in patients with heart failure and severe aortic stenosis439Biological factors linking depression and anxiety to cardiovascular disease440Troponins and myoglobin dynamic at coronary arteries graftingInvasive, non-invasive and molecular imaging443Diet composition effects on the genetic typing of the mouse ob mutation: a micro-ultrasound characterization of cardiac function, macro and micro circulation and liver steatosis444Characterization of pig coronary and rabbit aortic lesions using IV-OCT quantitative analysis: correlations with histologyGene therapy and cell therapy447Enhancing the survival and angiogenic potential of mouse atrial mesenchymal cells448VCAM-1 expression in experimental myocardial infarction and its relation to bone marrow-derived mononuclear cell retentionTissue engineering451Advanced multi layered scaffold that increases the maturity of stem cell-derived human cardiomyocytes452Response of engineered heart tissue to simulated ischemia/reperfusion in the presence of acute hyperglycemic conditions453Serum albumin hydrogels prevent de-differentiation of neonatal cardiomyocytes454A novel paintbrush technique for transfer of low viscosity ultraviolet light curable cyan methacrylate on saline immersed in-vitro sheep heart [O] . V Garcia-Martinez, C Lopez Sanchez, W Hamed, 2016

1. Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells: An In-Vitro Model to Predict Cardiac Effects of Drugs [J] . Romain Sube ,Eric A. Ertel . 生物医学工程（英文） . 2017,第11期

2. Induced pluripotent stem cells-derived human microglia-like cells to study pathological changes of Alzheimer disease [J] . XU Mei ,JIANG Ning ,ZHOU Wen-xia . 中国药理学与毒理学杂志 . 2018,第9期

3. Difference of urine-derived human induced pluripotent stem cells to alveolar typeⅡepithelial cells [J] . Chen Wang ,Zhihai Ju ,Jie Yu . 中国循环杂志 . 2016,第0z1期

4. Mucosal-associated invariant T cells from induced pluripotent stem cells:A novel approach for modeling human diseases [J] . Chie Sugimoto ,Hiroyoshi Fujita ,Hiroshi Wakao . 世界干细胞杂志：英文版（电子版） . 2016,第4期

5. 人类疱疹病毒6型中国地方株感染对外周血单个核细胞CD抗原表达及PHA诱导的增殖反应的影响 [C] . 季晓辉 . 中国微生物学会基础与临床病毒学会议 . 1998

6. 运用人类人工诱导多能干细胞衍生的视网膜类器官研究感光细胞分化中的视网膜色素上皮细胞和NRL基因的作用 [A] . TASNEEM AKHTAR . 2020